Leap Therapeutics, Inc.
LPTX
$0.3634
-$0.0056-1.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.67M | -18.18M | -20.13M | -13.82M | -12.47M |
| Total Depreciation and Amortization | 0.00 | 0.00 | -100.00K | 105.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.91M | 1.45M | 1.57M | 1.26M | 419.00K |
| Change in Net Operating Assets | -1.76M | 1.12M | 4.99M | -3.07M | 1.66M |
| Cash from Operations | -15.51M | -15.60M | -13.67M | -15.52M | -10.38M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 104.00K | 0.00 | 40.00M | 29.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -66.00K | -2.88M | -- | 0.00 |
| Cash from Financing | 104.00K | -66.00K | 37.12M | 29.00K | 0.00 |
| Foreign Exchange rate Adjustments | -166.00K | 10.00K | 112.00K | -235.00K | 280.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.57M | -15.66M | 23.56M | -15.72M | -10.10M |